MDWerks director granted 46,546 shares

Brocopp Timothy reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/29/2026 - 04:32 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Brocopp Timothy reported acquisition or exercise transactions in this Form 4 filing.

MDWerks, Inc. director Timothy Brocopp received a grant of 46,546 shares of common stock on May 15, 2026 at a price of $0.13 per share. This award was issued quarterly under his November 18, 2024 Employment Agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, with board approval under Rule 16b-3. Following this compensation grant, he holds 3,122,798 common shares directly.

Insider Trade Summary

Grant/Award: 46,546 shares

Grant/Award 1 txn

Insider Brocopp Timothy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	46,546	$0.13	$6K

Holdings After Transaction: Common Stock — 3,122,798 shares (Direct)

Holdings Before and After: Common Stock, 3,076,252 to 3,122,798 shares (Direct)

Footnotes (1)

1. F1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on November 18, 2024 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

Key Figures

Stock grant size: 46,546 shares Grant price: $0.13 per share Post-transaction holdings: 3,122,798 shares

3 metrics

Stock grant size 46,546 shares Common stock awarded on May 15, 2026

Grant price $0.13 per share Reported value for stock grant

Post-transaction holdings 3,122,798 shares Total common stock held directly after grant

Key Terms

Employment Agreement, 2025 Equity Incentive Plan, Rule 16b-3

3 terms

Employment Agreement financial

"pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on November 18, 2024"

2025 Equity Incentive Plan financial

"issued under the MDWerks, Inc. 2025 Equity Incentive Plan"

Rule 16b-3 regulatory

"issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MDWerks (MDWK) report for Timothy Brocopp?

MDWerks reported that director Timothy Brocopp received a grant of 46,546 common shares. The award was issued as part of his compensation, not an open-market purchase, and reflects stock-based pay approved by the company’s board under its equity plan.

At what price was Timothy Brocopp’s MDWerks (MDWK) stock grant recorded?

The 46,546-share grant to Timothy Brocopp was recorded at $0.13 per share. This value is used for reporting the stock-based award and comes from a quarterly issuance tied to his Employment Agreement and the company’s 2025 Equity Incentive Plan.

How many MDWerks (MDWK) shares does Timothy Brocopp hold after this Form 4 grant?

After the reported transaction, Timothy Brocopp directly holds 3,122,798 MDWerks common shares. This total includes the 46,546-share grant issued on May 15, 2026, reflecting his updated ownership position as disclosed in the Form 4 filing.

What is the source of Timothy Brocopp’s new MDWerks (MDWK) shares?

The new shares came from a quarterly stock grant under Brocopp’s November 18, 2024 Employment Agreement. They were issued pursuant to the MDWerks, Inc. 2025 Equity Incentive Plan and approved by the board in accordance with Rule 16b-3 under the Exchange Act.

Was Timothy Brocopp’s MDWerks (MDWK) transaction an open-market buy or a compensation award?

The filing describes the transaction as a grant or award acquisition, not an open-market buy. The 46,546 shares were issued as compensation under an Employment Agreement and equity incentive plan, with board approval under Rule 16b-3 rather than through a market purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brocopp Timothy

(Last) (First) (Middle)

411 WALNUT STREET,

SUITE 20125

(Street)

GREEN COVE SPRINGS, FLORIDA 32043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MDWerks, Inc. [ MDWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		A		46,546(1)	A	$0.13	3,122,798	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on November 18, 2024 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

	/s/ Timothy Brocopp	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)